Continuation of immunosuppressive treatment may be necessary in IgA nephropathy patients with remission of proteinuria: Evaluation by repeat renal biopsy

  • Authors:
    • Mian-Na Luo
    • Cui-Wei Yao
    • Bi-Hua Xu
    • Yong-Zhi Xu
    • Wei Jing Liu
    • Yong-Min Feng
    • Jing-Li Tao
    • Hua-Feng Liu
  • View Affiliations

  • Published online on: December 31, 2013     https://doi.org/10.3892/etm.2013.1467
  • Pages: 553-559
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study aimed to evaluate the effects of an individualized, low-dose multi-drug immunosuppressive regimen for the treatment of immunoglobulin A nephropathy (IgAN). A preliminary investigation of the course of IgAN following immunosuppressive treatment was conducted based on repeat renal biopsies. Clinical and pathological data of 17 patients with IgAN who received repeat renal biopsies were analyzed retrospectively. In addition to basic treatment, 16 patients regularly received an individualized low-dose immunosuppressive regimen according to their clinical manifestations and pathological patterns following the first biopsy. Clinical parameters, including 24-h urinary protein excretion and levels of serum albumin, uric acid and total cholesterol were collected. Glomerular deposits of IgA and C3, as well as the activity and chronicity indexes of renal lesions were evaluated by semi-quantitative methods. The 24‑h urinary protein excretion of the patients decreased significantly from the first biopsy (2.53±2.17 g/day) to the repeated biopsy (0.26±0.55 g/day) (P<0.001). Deposits of IgA and C3 in the glomerulus were persistent, but were reduced in quantity at the second biopsy. Although active renal lesions were observed in the majority of patients, the activity index decreased significantly from 3.18±1.33 prior to therapy to 2.47±0.80 following therapy (P<0.05), while the chronicity index did not change significantly (2.59±2.00 versus 2.76±1.89, respectively). The individualized, low-dose multi-drug immunosuppressive regimen used in the present study significantly minimized proteinuria, stabilized renal function and alleviated histological lesions in patients with IgAN without causing overt adverse effects during the short‑term follow-up. In addition to proteinuria, renal pathological changes should be appraised when considering the withdrawal of immunosuppressants from IgAN treatment.
View Figures
View References

Related Articles

Journal Cover

2014-March
Volume 7 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Luo M, Yao C, Xu B, Xu Y, Liu WJ, Feng Y, Tao J and Liu H: Continuation of immunosuppressive treatment may be necessary in IgA nephropathy patients with remission of proteinuria: Evaluation by repeat renal biopsy. Exp Ther Med 7: 553-559, 2014
APA
Luo, M., Yao, C., Xu, B., Xu, Y., Liu, W.J., Feng, Y. ... Liu, H. (2014). Continuation of immunosuppressive treatment may be necessary in IgA nephropathy patients with remission of proteinuria: Evaluation by repeat renal biopsy. Experimental and Therapeutic Medicine, 7, 553-559. https://doi.org/10.3892/etm.2013.1467
MLA
Luo, M., Yao, C., Xu, B., Xu, Y., Liu, W. J., Feng, Y., Tao, J., Liu, H."Continuation of immunosuppressive treatment may be necessary in IgA nephropathy patients with remission of proteinuria: Evaluation by repeat renal biopsy". Experimental and Therapeutic Medicine 7.3 (2014): 553-559.
Chicago
Luo, M., Yao, C., Xu, B., Xu, Y., Liu, W. J., Feng, Y., Tao, J., Liu, H."Continuation of immunosuppressive treatment may be necessary in IgA nephropathy patients with remission of proteinuria: Evaluation by repeat renal biopsy". Experimental and Therapeutic Medicine 7, no. 3 (2014): 553-559. https://doi.org/10.3892/etm.2013.1467